IL309179A - Nucleic acid coding for KLK2-GPI fusion protein, recombinant cells and their uses - Google Patents
Nucleic acid coding for KLK2-GPI fusion protein, recombinant cells and their usesInfo
- Publication number
- IL309179A IL309179A IL309179A IL30917923A IL309179A IL 309179 A IL309179 A IL 309179A IL 309179 A IL309179 A IL 309179A IL 30917923 A IL30917923 A IL 30917923A IL 309179 A IL309179 A IL 309179A
- Authority
- IL
- Israel
- Prior art keywords
- klk2
- nucleic acid
- fusion protein
- recombinant cells
- acid coding
- Prior art date
Links
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 title 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21035—Tissue kallikrein (3.4.21.35)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/90—Fusion polypeptide containing a motif for post-translational modification
- C07K2319/91—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation
- C07K2319/912—Fusion polypeptide containing a motif for post-translational modification containing a motif for glycosylation containing a GPI (phosphatidyl-inositol glycane) anchor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16041—Use of virus, viral particle or viral elements as a vector
- C12N2740/16043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163209019P | 2021-06-10 | 2021-06-10 | |
| PCT/IB2022/055355 WO2022259190A1 (en) | 2021-06-10 | 2022-06-08 | Nucleic acid coding for klk2-gpi fusion protein, recombinant cells, and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL309179A true IL309179A (en) | 2024-02-01 |
Family
ID=82358484
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL309179A IL309179A (en) | 2021-06-10 | 2022-06-08 | Nucleic acid coding for KLK2-GPI fusion protein, recombinant cells and their uses |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220403397A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4352217A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024520790A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240021211A (cg-RX-API-DMAC7.html) |
| CN (1) | CN117480253A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022291273A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112023025616A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3222756A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL309179A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023014793A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022259190A1 (cg-RX-API-DMAC7.html) |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4873191A (en) | 1981-06-12 | 1989-10-10 | Ohio University | Genetic transformation of zygotes |
| US5175384A (en) | 1988-12-05 | 1992-12-29 | Genpharm International | Transgenic mice depleted in mature t-cells and methods for making transgenic mice |
| GB8901778D0 (en) | 1989-01-27 | 1989-03-15 | Univ Court Of The University O | Manipulatory technique |
| US5585362A (en) | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
| ATE237694T1 (de) | 1991-08-20 | 2003-05-15 | Us Gov Health & Human Serv | Adenovirus vermittelter gentransfer in den gastrointestinaltrakt |
| FR2688514A1 (fr) | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
| US5602299A (en) | 1992-09-23 | 1997-02-11 | Mount Sinai School Of Medicine Of The City University Of New York | Transgenic animal models for neurodegenerative disease |
| EP0673431A1 (en) | 1992-12-03 | 1995-09-27 | Genzyme Corporation | Gene therapy for cystic fibrosis |
| EP0705344B8 (en) | 1993-06-24 | 2006-05-10 | Advec Inc. | Adenovirus vectors for gene therapy |
| US5516639A (en) * | 1993-07-22 | 1996-05-14 | Mayo Foundation For Medical Education And Research | Antibodies specific for human prostate glandular kallkrein |
| DE69435223D1 (de) | 1993-10-25 | 2009-09-03 | Canji Inc | Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung |
| JPH07132033A (ja) | 1993-11-12 | 1995-05-23 | Hoechst Japan Ltd | アルツハイマー病モデルトランスジェニック動物 |
| US6113917A (en) * | 1995-04-25 | 2000-09-05 | Rmf Dictagene S.A. | Modified polypeptides for enhanced immunogenicity |
| US6066778A (en) | 1996-11-06 | 2000-05-23 | The Regents Of The University Of Michigan | Transgenic mice expressing APC resistant factor V |
| WO2004098529A2 (en) * | 2003-04-30 | 2004-11-18 | Emory University | Therapeutic compositions and vaccines by glycosyl-phosphatidylinositol (gpi)-anchored cytokines and immunostimulatory molecules |
| JP4549666B2 (ja) * | 2003-12-12 | 2010-09-22 | タカラバイオ株式会社 | 抗体の製造方法 |
| ATE440949T1 (de) * | 2004-01-30 | 2009-09-15 | Maxygen Holdings Ltd | Gesteuertes überlesen von stopcodons |
| KR20070084330A (ko) * | 2004-10-18 | 2007-08-24 | 지모제넥틱스, 인코포레이티드 | 가용성 zcytor21, 항-zcytor21 항체 및 결합파트너 및 염증에서의 사용방법 |
| EP2315846A4 (en) * | 2008-08-05 | 2011-11-30 | Univ Rochester | PSA AND KLK2 AS THERAPEUTIC TARGET MOLECULES AND PSA AND KLK2-INHIBITABLE MOLECULES |
| JP6092782B2 (ja) * | 2010-11-16 | 2017-03-08 | エクセリミューン, インコーポレイテッド | 組換えタンパク質の製造方法 |
| EP3218477A4 (en) * | 2014-11-10 | 2018-07-18 | The Board of Trustees of The Leland Stanford Junior University | Compositions and methods for expressing polypeptides on the surface of cells |
| TW202118792A (zh) * | 2019-07-26 | 2021-05-16 | 美商健生生物科技公司 | 抗hk2嵌合抗原受體(car) |
-
2022
- 2022-06-08 WO PCT/IB2022/055355 patent/WO2022259190A1/en not_active Ceased
- 2022-06-08 EP EP22735984.1A patent/EP4352217A1/en active Pending
- 2022-06-08 IL IL309179A patent/IL309179A/en unknown
- 2022-06-08 KR KR1020247000497A patent/KR20240021211A/ko active Pending
- 2022-06-08 JP JP2023575724A patent/JP2024520790A/ja active Pending
- 2022-06-08 AU AU2022291273A patent/AU2022291273A1/en active Pending
- 2022-06-08 US US17/835,671 patent/US20220403397A1/en active Pending
- 2022-06-08 MX MX2023014793A patent/MX2023014793A/es unknown
- 2022-06-08 BR BR112023025616A patent/BR112023025616A2/pt not_active Application Discontinuation
- 2022-06-08 CA CA3222756A patent/CA3222756A1/en active Pending
- 2022-06-08 CN CN202280041004.7A patent/CN117480253A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| BR112023025616A2 (pt) | 2024-02-27 |
| EP4352217A1 (en) | 2024-04-17 |
| JP2024520790A (ja) | 2024-05-24 |
| WO2022259190A1 (en) | 2022-12-15 |
| US20220403397A1 (en) | 2022-12-22 |
| MX2023014793A (es) | 2024-03-25 |
| AU2022291273A1 (en) | 2024-01-25 |
| CA3222756A1 (en) | 2022-12-15 |
| CN117480253A (zh) | 2024-01-30 |
| KR20240021211A (ko) | 2024-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12019501413A1 (en) | T-cell modulatory multimeric polypeptides and method of use thereof | |
| TW202617984A (zh) | Dna修飾酶及活性片段,及其變異體與使用方法 | |
| IL276469A (en) | Non-viral DNA vectors and their uses for the production of antibody and fusion protein | |
| WO2010120514A3 (en) | Antigen-binding proteins comprising recombinant protein scaffolds | |
| BR112014020694A2 (pt) | proteína de fusão do fator viii compreendendo polipeptídeo do fator viii fusionado a polipeptí-deo recombinante estendido (xten) e seu método de fabricação, ácido nucleico, vetores, célula hospedeira, bem como composição farmacêutica e seu uso no tratamento de coagulopatia, episódio de hemorragia e hemofilia a | |
| AU2017266905A1 (en) | Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereof | |
| EP4219702A3 (en) | Enzyme variants and polynucleotides encoding the same | |
| EP4328304A3 (en) | Engineered cleavage half-domains | |
| WO2010082804A3 (en) | Method for producing physiologically active protein or peptide using immunoglobulin fragment | |
| WO2004099370A3 (en) | NOVEL BACILLUS mHKcel CELLULASE | |
| ATE492633T1 (de) | Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide | |
| MX2023010640A (es) | Péptidos neoantigénicos transmembranales. | |
| WO2016130628A8 (en) | Griffithsin mutants | |
| GB202303798D0 (en) | Nucleic acid constructs for expressing polypeptides in cells | |
| EP3976104A4 (en) | ANTI-CSF1R ANTIBODIES, IL10 FUSION PROTEINS AND THEIR USES | |
| SG11202009503PA (en) | Engineered cells with modified host cell protein profiles | |
| BRPI0813743A2 (pt) | Método para produzir trombina humana recombinante, trombina recombinante, composição farmacêutica, sequência de dna isolada, vetor, sequência de aminoácido, e, célula hospedeira. | |
| WO2004025264A3 (en) | Rapidly degraded reporter fusion proteins | |
| CO2017011431A2 (es) | Proteínas de fusión de receptor de factor de crecimiento epidermal variante iii - mesotelina | |
| WO2013070796A3 (en) | Propeptide-luciferase fusion proteins and methods of use thereof | |
| HK40109642A (en) | Nucleic acid coding for klk2-gpi fusion protein, recombinant cells, and uses thereof | |
| EP4538296A4 (en) | Glycosyl-modified fusion protein, nucleic acid molecule, expression vector, host cell and use | |
| IL319272A (en) | ROVEL FUSION protein specific for CD137 and CD228 | |
| ZA201105921B (en) | Fusion proteins,preparation process thereof and their use in recombinant protein expression systems | |
| GB202200745D0 (en) | CRA4S1 gene, encoded CRA4S1 protein, and application |